Literature DB >> 20797891

Long-term quality of life in patients with rectal cancer treated with preoperative (chemo)-radiotherapy within a randomized trial.

M Tiv1, M Puyraveau, L Mineur, G Calais, P Maingon, E Bardet, M Mercier, J-F Bosset.   

Abstract

PURPOSE: Few studies have evaluated the quality of life (QoL) of patients with rectal cancer. This report describes the quality of life of French patients who entered the 22921 EORTC trial that investigated the role and place of chemotherapy (CT) added to preoperative radiotherapy (preop-RT). PATIENTS AND METHODS: Patients without recurrences were evaluated with EORTC QLQ-C30 and QLQ-CR38 questionnaires, after a median time of 4.6 years from randomisation.
RESULTS: All the scores of QLQ-C30 functions were high, from 78 up to 88, with those of global health quality of life scale (GHQL) status being 73. The mean scores of symptoms were low except for diarrhoea. For QLQ-CR38, the mean scores for "body image" and "future perspective" were high at 79.6 and 69.7 respectively. The scores for "sexual functioning" and "enjoyment" were low. Men had more sexual problems than females (62.5 vs 25 mean scores respectively). Chemotherapy was associated with more diarrhoea complaints, lower "role", lower "social functioning" and lower global health quality of life scale.
CONCLUSION: The overall quality of life of patients with rectal cancer is quite good 4.6 years after the beginning preoperative treatments. However, adding chemotherapy to preoperative radiotherapy has a negative effect on diarrhoea complaints and some quality of life dimensions.
Copyright © 2010 Société française de radiothérapie oncologique (SFRO). Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20797891     DOI: 10.1016/j.canrad.2010.06.017

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  14 in total

1.  Erectile and urinary function in men with rectal cancer treated by neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy alone: a randomized trial report.

Authors:  Meijin Huang; Jinxin Lin; Xihu Yu; Shen Chen; Liang Kang; Yanhong Deng; Jian Zheng; Yanxin Luo; Lei Wang; Ping Lan; Jianping Wang
Journal:  Int J Colorectal Dis       Date:  2016-06-06       Impact factor: 2.571

2.  Predictors of Long-Term Quality of Life for Survivors of Stage II/III Rectal Cancer in the Cancer Care Outcomes Research and Surveillance Consortium.

Authors:  Mary E Charlton; Karyn B Stitzenberg; Chi Lin; Jennifer A Schlichting; Thorvardur R Halfdanarson; Grelda Yazmin Juarez; Jane F Pendergast; Elizabeth A Chrischilles; Robert B Wallace
Journal:  J Oncol Pract       Date:  2015-06-16       Impact factor: 3.840

3.  The impact of radiotherapy on quality of life for cancer patients: a longitudinal study.

Authors:  Birsen Yucel; Ebru Atasever Akkaş; Yillar Okur; Ayfer Ay Eren; Mehmet Fuat Eren; Hanife Karapinar; Nalan Akgül Babacan; Saadettin Kiliçkap
Journal:  Support Care Cancer       Date:  2014-04-12       Impact factor: 3.603

4.  Sacral neuromodulation for fecal incontinence and "low anterior resection syndrome" following neoadjuvant therapy for rectal cancer.

Authors:  O Schwandner
Journal:  Int J Colorectal Dis       Date:  2013-04-05       Impact factor: 2.571

Review 5.  Neo-adjuvant radiotherapy in rectal cancer.

Authors:  Bengt Glimelius
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

Review 6.  Synthesis and summary of patient-reported outcome measures to inform the development of a core outcome set in colorectal cancer surgery.

Authors:  A G K McNair; R N Whistance; R O Forsythe; J Rees; J E Jones; A M Pullyblank; K N L Avery; S T Brookes; M G Thomas; P A Sylvester; A Russell; A Oliver; D Morton; R Kennedy; D G Jayne; R Huxtable; R Hackett; S J Dutton; M G Coleman; M Card; J Brown; J M Blazeby
Journal:  Colorectal Dis       Date:  2015-11       Impact factor: 3.788

7.  A Retrospective Analysis on Two-week Short-course Pre-operative Radiotherapy in Elderly Patients with Resectable Locally Advanced Rectal Cancer.

Authors:  Chen Shi; Hao Zhou; Xiaofan Li; Yong Cai
Journal:  Sci Rep       Date:  2016-11-25       Impact factor: 4.379

Review 8.  On a prolonged interval between rectal cancer (chemo)radiotherapy and surgery.

Authors:  Bengt Glimelius
Journal:  Ups J Med Sci       Date:  2017-02-24       Impact factor: 2.384

9.  Late assessment of quality of life in patients with rectal carcinoma: comparison between sphincter preservation and definitive colostomy.

Authors:  Mariane Messias Reis Lima Silva; Samuel Aguiar Junior; Juliana de Aguiar Pastore; Érica Maria Monteiro Santos; Fábio de Oliveira Ferreira; Ranyell Matheus S B Spencer; Vinicius F Calsavara; Wilson Toshihiko Nakagawa; Ademar Lopes
Journal:  Int J Colorectal Dis       Date:  2018-04-19       Impact factor: 2.571

Review 10.  Optimal Time Intervals between Pre-Operative Radiotherapy or Chemoradiotherapy and Surgery in Rectal Cancer?

Authors:  Bengt Glimelius
Journal:  Front Oncol       Date:  2014-04-07       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.